ABVC BioPharma Inc.

NASDAQ: ABVC · Real-Time Price · USD
3.09
0.24 (8.42%)
At close: Aug 20, 2025, 3:59 PM
3.09
0.00%
After-hours: Aug 20, 2025, 07:41 PM EDT

ABVC BioPharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-3.23M -1.91M -3.9M -7.24M -10.42M -11.72M -10.69M -12.08M -12.49M -12.12M -16.31M -18.71M -16.82M -16.93M -12.04M -10.1M -10.35M -10.48M
Depreciation & Amortization
381.11K 313.58K 302.18K 130.45K 130.89K 124.58K 28.53K 27.38K 26.39K 24.88K 23.8K 20.63K 17.03K 14.48K 11.99K 15.54K 21.41K 28.9K
Stock-Based Compensation
1.44M 277.24K 2.26M 2.67M 3.49M 3.3M 1.64M 3.3M 2.71M 2.71M 7.04M 9.52M 9.52M 9.77M 5.31M 4.07M 4.85M 4.37M
Other Working Capital
-275.63K -473.68K -609.99K -316.16K -196.32K 809.74K 894.64K 2.78M 5.17M 2.67M 1.25M -1.37M -4.64M -2.96M -1.5M -915.47K -28.28K -244.42K
Other Non-Cash Items
-377.03K -57.09K 212.09K 3.35M 4.31M 4.39M 3.85M 1.26M 495.49K 342.01K 353.04K 525.05K -49.2K -4.94K -91.05K 48.67K 974.84K 2.01M
Deferred Income Tax
n/a n/a n/a 151.39K 33.97K 115.67K 115.67K 860.33K 1.12M 951.67K 864.8K 980.01K 765.47K 788.36K 824.2K -273.46K -242.53K -233.66K
Change in Working Capital
38.2K -495.45K -814.78K -987.19K -998.01K 454.52K 821.26K 2.41M 4.77M 2.19M 635.57K -1.33M -4.6M -2.82M -1.61M -1.49M -626.97K -1.04M
Operating Cash Flow
-1.76M -1.88M -1.94M -1.92M -3.45M -3.34M -4.24M -4.22M -3.37M -5.9M -7.4M -8.99M -11.16M -9.18M -7.6M -7.73M -5.37M -5.35M
Capital Expenditures
-3 n/a -4 21.2K -1 -4 n/a -21.29K -4.45K -26.47K -119.69K 162.35K 166.71K 188.73K n/a -281.95K -281.95K -281.95K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a -83.2K -1.6M -1.6M -1.6M -1.56M -258.94K -258.94K -258.94K -214.2K n/a n/a
Purchase of Investments
n/a n/a n/a 154.17K 101.59K -338.99K -338.99K -576.36K -2.04M -1.51M -1.51M -1.42M 96.37K 3.15K 3.15K n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a 166.4K 3.2M 3.2M 3.2M 2.49M -550.18K -550.18K -550.18K 10.72K 114.5K 114.5K
Other Investing Acitivies
-665.78K n/a n/a -21.2K -21.2K -461.78K -461.78K -523.77K -2.04M -1.7M -1.7M -1.34M 46.8K n/a n/a -171.83K -513.26K -339.94K
Investing Cash Flow
-665.78K n/a n/a 154.17K 80.39K -360.19K -360.19K -597.65K -2.05M -1.63M -1.72M -1.68M -499.24K -617.23K -805.97K -657.27K -680.71K -507.38K
Debt Repayment
-295.42K -271.09K 70.25K 267.41K -1.38M -1.43M 1.46M 1.35M 3.52M 3.56M 350K 358.36K -98.74K -159.97K -158.19K 1.24M 1.83M 1.64M
Common Stock Repurchased
-7.32K -7.32K -7.32K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
2.65M 831.57K 1M 193.66K 2.75M 2.65M 1.43M 1.43M -1M -1M n/a n/a -950.43K -965.71K -965.71K -965.71K -508.76K -518.17K
Financial Cash Flow
2.79M 1.73M 2.23M 1.73M 3.54M 2.64M 3.92M 3.58M 2.52M 6.22M 4.01M 8.52M 13.73M 9.95M 10M 12.61M 7.24M 9M
Net Cash Flow
16.8K 100.57K 147.03K -351.06K 580.00 -1.13M -674.95K -849.21K -2.86M -1.64M -5.17M -2.48M 1.94M 99.35K 1.56M 4.3M 1.25M 3.19M
Free Cash Flow
-1.76M -1.88M -1.94M -1.89M -3.44M -3.32M -4.22M -4.24M -3.38M -5.93M -7.52M -8.83M -11M -8.99M -7.6M -8.01M -5.66M -5.63M